Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Most patients experienced significant but reversible hair loss during treatment.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

A woman's ovarian tumor causing high testosterone was successfully removed, and her symptoms improved.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

PCOS may increase the risk of certain cancers.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

People undergoing chemotherapy need better support and information to cope with hair loss.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

PCOS is a complex condition that can lead to serious health issues, but early diagnosis and treatment can reduce these risks.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

A woman with PCOS successfully overcame secondary infertility and became pregnant with triplets after treatment.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

150 kHz electromagnetic radiation might help improve PCOS in rats.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.